Insys Therapeutics (INSY) – Analyst EPS View
-
INSYS Therapeutics (INSY) PT Lowered to $14 at Jefferies Following Q4 Report; 'Sharp Rx Decline in Q1'
-
Insys Therapeutics (INSY): Cutting Ests On RX Slowdown - Jefferies
-
-
-
-
-
-
-
Back to INSY Stock Lookup